These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31865744)

  • 21. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD.
    Vozoris NT; Wang X; Fischer HD; Bell CM; O'Donnell DE; Austin PC; Stephenson AL; Gill SS; Rochon PA
    Eur Respir J; 2016 Sep; 48(3):683-93. PubMed ID: 27418553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis.
    Goodridge D; Lawson J; Rocker G; Marciniuk D; Rennie D
    Int J Chron Obstruct Pulmon Dis; 2010 May; 5():99-105. PubMed ID: 20461142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Vozoris NT
    Am J Respir Crit Care Med; 2021 Jan; 203(2):266-267. PubMed ID: 33022187
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
    Moran T; Zentner D; Wong J; Philip J; Smallwood N
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
    Ahmadi Z; Bernelid E; Currow DC; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
    Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
    BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
    [No Abstract]   [Full Text] [Related]  

  • 28. Opioids, Chronic Obstructive Pulmonary Disease, and Hyperbole.
    Vozoris NT
    J Palliat Med; 2018 Jun; 21(6):745. PubMed ID: 29889015
    [No Abstract]   [Full Text] [Related]  

  • 29. Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches.
    Ora J; Jensen D; O'Donnell DE
    Curr Opin Pulm Med; 2010 Mar; 16(2):144-9. PubMed ID: 19926997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The need to address increasing opioid use in elderly COPD patients.
    Vozoris NT; O'Donnell DE
    Expert Rev Respir Med; 2016; 10(3):245-8. PubMed ID: 26783198
    [No Abstract]   [Full Text] [Related]  

  • 31. Opioid drug use in emergency and adverse outcomes among patients with chronic obstructive pulmonary disease: a multicenter observational study.
    Viglino D; Daoust R; Bailly S; Faivre-Pierret C; Charif I; Roustit M; Paquet J; Debaty G; Pépin JL; Maignan M; Chauny JM
    Sci Rep; 2020 Mar; 10(1):5038. PubMed ID: 32193505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
    Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
    Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative management of refractory dyspnea in COPD.
    Uronis HE; Currow DC; Abernethy AP
    Int J Chron Obstruct Pulmon Dis; 2006; 1(3):289-304. PubMed ID: 18046866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of COPD in End-of-Life Care by Spanish Pulmonologists.
    Ecenarro PS; Iguiñiz MI; Tejada SP; Malanda NM; Imizcoz MA; Marlasca LA; Navarrete BA
    COPD; 2018 Apr; 15(2):171-176. PubMed ID: 29558226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary issues in refractory dyspnoea in advanced chronic obstructive pulmonary disease.
    Horton R; Rocker G
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):56-62. PubMed ID: 20407378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The New "Opioid Crisis": Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea.
    Rocker G; Bourbeau J; Downar J
    J Palliat Med; 2018 Feb; 21(2):120-122. PubMed ID: 29393775
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse cardiac events associated with incident opioid drug use among older adults with COPD.
    Vozoris NT; Wang X; Austin PC; Lee DS; Stephenson AL; O'Donnell DE; Gill SS; Rochon PA
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1287-1295. PubMed ID: 28664359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.
    Vozoris NT; Wang X; Fischer HD; Gershon AS; Bell CM; Gill SS; O'Donnell DE; Austin PC; Stephenson AL; Rochon PA
    Br J Clin Pharmacol; 2016 Jan; 81(1):161-70. PubMed ID: 26337922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing dyspnea in advanced chronic obstructive pulmonary disease: balancing all the evidence.
    Mularski RA; Rocker G
    Ann Am Thorac Soc; 2015 Jul; 12(7):978-80. PubMed ID: 26203609
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of inhaled opioids and furosemide for the treatment of dyspnea.
    Kallet RH
    Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.